Wellington-based cancer technology company Volpara Health Technologies has announced its latest contract – the highest value one to date – through its new US-based subsidiary.
The ASX-listed company announced on Friday a deal to provide its integrated breast cancer platform, which is
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
